Ivermectin’s Place Amid J&J’s $2B U.S. Drug Manufacturing Expansion
In 2025, Johnson & Johnson (J&J) announced a $2 billion investment to expand its U.S. drug manufacturing capacity, strengthening the country’s ability.....
.
menu
